
Sign up to save your podcasts
Or


Blockbuster drugs are launched by the pharmaceuticals industry to great fanfare — with promises of treating intractable illness and often with a stratospheric price tag. Yet, despite the hype and cost, many of those drugs turn out to be less than useless. How is it that so many drugs that are vetted by the Food and Drug Administration escape real scrutiny? Jerry Avorn, one of the most cited scientists in medicine, discusses the deeply compromised state of drug production and government regulation, in thrall to a for-profit system. (Encore presentation.)
Jerry Avorn, Rethinking Medications: Truth, Power, and the Drugs You Take Simon & Schuster, 2025
Alosa Health
Center for Science in the Public Interest
Worst Pills, Best Pills
The post Medicines: Expensive, Poorly Tested, and Often Useless appeared first on KPFA.
By KPFA4.8
201201 ratings
Blockbuster drugs are launched by the pharmaceuticals industry to great fanfare — with promises of treating intractable illness and often with a stratospheric price tag. Yet, despite the hype and cost, many of those drugs turn out to be less than useless. How is it that so many drugs that are vetted by the Food and Drug Administration escape real scrutiny? Jerry Avorn, one of the most cited scientists in medicine, discusses the deeply compromised state of drug production and government regulation, in thrall to a for-profit system. (Encore presentation.)
Jerry Avorn, Rethinking Medications: Truth, Power, and the Drugs You Take Simon & Schuster, 2025
Alosa Health
Center for Science in the Public Interest
Worst Pills, Best Pills
The post Medicines: Expensive, Poorly Tested, and Often Useless appeared first on KPFA.

5,825 Listeners

1,985 Listeners

1,858 Listeners

147 Listeners

518 Listeners

1,460 Listeners

66 Listeners

1,210 Listeners

57 Listeners

23 Listeners

53 Listeners

1,590 Listeners

48 Listeners

51 Listeners

270 Listeners

21 Listeners

156 Listeners

6,122 Listeners

1,012 Listeners

2,707 Listeners

605 Listeners

290 Listeners

375 Listeners

485 Listeners